Armed Bandits in Brazil Pursue New Loot: Ozempic

Criminals are targeting pharmacies and stealing weight-loss medication in a country with body image insecurities and where many cannot afford the drugs.

New Insights Into Older Hearts

Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for older heart patients.

Ladrones de Ozempic: la nueva ola delictiva en Brasil

En un país obsesionado con la imagen corporal, bandas delictivas roban medicamentos para perder peso que muchos brasileños codician pero que la mayoría no puede permitirse.

The Pharmaceutical Industry Heads Into Elon Musk’s Wood Chipper

Who needs N.I.H. grants? A lot of red-state universities, for one.

¿Sirve la testosterona para las mujeres después de la menopausia?

La demanda de esta hormona está aumentando, y no solo para tratar la libido. Esto es lo que hay que saber.

Cuando los medicamentos para perder peso afectan a un matrimonio

Un cambio radical, en teoría positivo, podría representar el fin de la compatibilidad.

Dozens of Clinical Trials Have Been Frozen in Response to Trump’s USAID Order

The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their bodies, with no access to monitoring or care.

Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.

Testosterone Therapy for Menopause: What the Hormone Can, and Cannot, Do

Demand for the hormone is surging, and not just to treat libido. Here’s what we know about its benefits, and potential risks.

How an Activist Group Helped Torpedo MDMA Therapy

The fallout from the F.D.A.’s rejection of a new treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.